Long non-coding RNA EGOT is associated with 131iodine sensitivity and contributes to thyroid cancer progression by targeting miR-641/PTEN axis
Aging · 2023
DOI: 10.18632/aging.205284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Ming Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid-Head and Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, Jilin Province, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Iodine, Thyroid Neoplasms, MicroRNAs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid-Head and Neck Oncosurgery-1, Jilin Cancer Hospital, Changchun, Jilin Province, China.
- Department of Thoracic Oncosurgery-1, Jilin Cancer Hospital, Changchun, Jilin Province, China.
- Department of Gynecologic Oncosurgery-2, Jilin Cancer Hospital, Changchun, Jilin Province, China.
- Department of Breast Oncosurgery-2, Jilin Cancer Hospital, Changchun, Jilin Province, China.
Zitieren
APA
Wang, M., Wei, Z., Wang, S., Feng, W., Shang, L., & Sun, X. (2023). Long non-coding RNA EGOT is associated with 131iodine sensitivity and contributes to thyroid cancer progression by targeting miR-641/PTEN axis. Aging. https://doi.org/10.18632/aging.205284
Vancouver
Wang M, Wei Z, Wang S, Feng W, Shang L, Sun X. Long non-coding RNA EGOT is associated with 131iodine sensitivity and contributes to thyroid cancer progression by targeting miR-641/PTEN axis. Aging. 2023. doi:10.18632/aging.205284
BibTeX
@article{Wang2023,
author = {Wang, Ming and Wei, Zhengchao and Wang, Shuang and Feng, Wenjuan and Shang, Lihua and Sun, Xiaosong},
title = {Long non-coding RNA EGOT is associated with 131iodine sensitivity and contributes to thyroid cancer progression by targeting miR-641/PTEN axis},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205284}
}
EUVIMED